The Online Investor
OncoSec Medical Inc (ONCS)

OncoSec Medical is a late-stage immuno-oncology company focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Co.'s main technology, ImmunoPulse®, is a drug-device therapeutic modality platform comprised of OncoSec Medical System EP device (the OMS EP Device) and a DNA plasmid delivery and application method. The OMS EP Device can be adapted to treat various tumor types, and consists of an electrical pulse generator and disposable applicator. Co.'s main product candidate is a plasmid encoding interleukin-12 called tavokinogene telseplasmid.
Company Name: 
OncoSec Medical Inc
Website: 
www.oncosec.com
Sector: 
Biotechnology
Quotes delayed 20 minutes

Email EnvelopeFree ONCS Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
ONCS Stock Forecast

Based on Zacks ABR data;
powered by Xignite

OncoSec Medical Inc (ONCS) Page | The Online Investor Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.